FIELD: pharmaceuticals.
SUBSTANCE: present invention refers to immunology. Proposed is a antibody or antigen-binding fragment thereof that specifically binds to human shed folate receptor 1 (FOLR1). Also disclosed is a nucleic acid molecule, a method for detecting a FOLR1 protein in a sample, a cell and a method for producing an antibody or antigen-binding fragment thereof. In addition, an immunoassay kit for detecting FOLR1 protein in a sample is described.
EFFECT: present invention can be used in the diagnosis and treatment of cancer.
14 cl, 15 dwg, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC ANALYSES AND KITS FOR DETECTION OF FOLATE RECEPTOR 1 | 2018 |
|
RU2788126C2 |
| METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
| ANTIBODIES TO FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND APPLICATION | 2011 |
|
RU2610663C2 |
| ANTIBODIES AND ANALYSIS METHODS FOR FOLIC ACID 1 RECEPTOR DETECTION | 2014 |
|
RU2725825C2 |
| ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE | 2011 |
|
RU2740479C2 |
| ANTI-FOLR1 IMMUNOCONJUGATE DOSING REGIMENS | 2014 |
|
RU2696579C2 |
| ANTI-FOLR1 IMMUNOCONJUGATE APPLICATION SCHEMES | 2014 |
|
RU2801307C1 |
| ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF | 2011 |
|
RU2595403C2 |
| AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE | 2009 |
|
RU2579897C2 |
| THERAPEUTIC COMBINATIONS CONTAINING ANTI-FOLR1 IMMUNOCONJUGATES | 2016 |
|
RU2749865C2 |
